[Continued ambulatory therapy of schizophrenic patients using injectable delayed-action neuroleptic drugs].
D000978:Antiparkinson Agents / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D010879:Piperazines / Q000627:therapeutic use; D011596:Psychomotor Disorders / Q000139:chemically induced / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*; D013141:Spiro Compounds / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014966:Xanthenes / Q000627:therapeutic use
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D010879:Piperazines; D013141:Spiro Compounds; D014149:Tranquilizing Agents; D014966:Xanthenes; D005476:Fluphenazine
Ambulante Weiterbehandlung schizophrener Patienten mit injizierbaren Depot-Neuroleptika.